HEADER TRANSCRIPTION 17-JUN-02 1M13 TITLE CRYSTAL STRUCTURE OF THE HUMAN PREGANE X RECEPTOR LIGAND BINDING TITLE 2 DOMAIN IN COMPLEX WITH HYPERFORIN, A CONSTITUENT OF ST. JOHN'S WORT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORPHAN NUCLEAR RECEPTOR PXR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: INCLUDES LIGAND BINDING DOMAIN (RESIDUES 130-434); COMPND 5 SYNONYM: PREGNANE X RECEPTOR, ORPHAN NUCLEAR RECEPTOR PAR1, STEROID COMPND 6 AND XENOBIOTIC RECEPTOR, SXR; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2 OR PXR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSETA KEYWDS NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, PROTEIN-LIGAND COMPLEX, KEYWDS 2 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR R.E.WATKINS,J.M.MAGLICH,L.B.MOORE,G.B.WISELY,S.M.NOBLE,P.R.DAVIS- AUTHOR 2 SEARLES,M.H.LAMBERT,S.A.KLIEWER,M.R.REDINBO REVDAT 3 14-FEB-24 1M13 1 REMARK SEQADV REVDAT 2 24-FEB-09 1M13 1 VERSN REVDAT 1 04-MAR-03 1M13 0 JRNL AUTH R.E.WATKINS,J.M.MAGLICH,L.B.MOORE,G.B.WISELY,S.M.NOBLE, JRNL AUTH 2 P.R.DAVIS-SEARLES,M.H.LAMBERT,S.A.KLIEWER,M.R.REDINBO JRNL TITL 2.1 A CRYSTAL STRUCTURE OF HUMAN PXR IN COMPLEX WITH THE ST. JRNL TITL 2 JOHN'S WORT COMPOUND HYPERFORIN JRNL REF BIOCHEMISTRY V. 42 1430 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 12578355 JRNL DOI 10.1021/BI0268753 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.87 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 20167 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 998 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1861 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE : 0.2780 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 111 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2140 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 265 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.39000 REMARK 3 B22 (A**2) : 1.39000 REMARK 3 B33 (A**2) : -2.79000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.750 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.590 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.600 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 10.760; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 12.000; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 49.60 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : HYP5.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : HYP5.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1M13 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-JUN-02. REMARK 100 THE DEPOSITION ID IS D_1000016466. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC CONFOCAL BLUE OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20273 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 19.870 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.37700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ISOPROPANOL, TRIS-HCL, SODIUM REMARK 280 CHLORIDE, GLYCEROL, EDTA, DTT, SODIUM AZIDE, PH 7.6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.82250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.68600 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.68600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.23375 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.68600 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.68600 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 21.41125 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.68600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.68600 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 64.23375 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.68600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.68600 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 21.41125 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 42.82250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 119 REMARK 465 LYS A 120 REMARK 465 LYS A 121 REMARK 465 GLY A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 HIS A 127 REMARK 465 HIS A 128 REMARK 465 GLY A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 GLN A 141 REMARK 465 LEU A 178 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 SER A 192 REMARK 465 ARG A 193 REMARK 465 GLU A 194 REMARK 465 GLU A 195 REMARK 465 ALA A 196 REMARK 465 ALA A 197 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 146 CG CD OE1 OE2 REMARK 470 LYS A 170 CD CE NZ REMARK 470 VAL A 177 CG1 CG2 REMARK 470 LYS A 198 CG CD CE NZ REMARK 470 TRP A 199 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 199 CZ3 CH2 REMARK 470 SER A 200 OG REMARK 470 GLN A 201 CG CD OE1 NE2 REMARK 470 VAL A 202 CG1 CG2 REMARK 470 ARG A 203 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 204 CG CD CE NZ REMARK 470 CYS A 207 SG REMARK 470 GLU A 218 CG CD OE1 OE2 REMARK 470 LYS A 226 CD CE NZ REMARK 470 SER A 231 OG REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 GLU A 235 CG CD OE1 OE2 REMARK 470 ASP A 310 CG OD1 OD2 REMARK 470 THR A 311 OG1 CG2 REMARK 470 PHE A 315 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 316 CG CD OE1 NE2 REMARK 470 GLN A 317 CG CD OE1 NE2 REMARK 470 LYS A 332 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 204 14.56 -68.26 REMARK 500 SER A 208 19.47 -67.43 REMARK 500 LYS A 210 105.24 -161.24 REMARK 500 GLU A 218 9.89 -69.95 REMARK 500 PRO A 228 -160.31 -77.40 REMARK 500 SER A 231 67.68 -161.09 REMARK 500 LYS A 234 -75.82 -3.00 REMARK 500 GLU A 235 -59.33 -2.10 REMARK 500 ILE A 236 3.08 -66.46 REMARK 500 CYS A 301 68.65 -106.47 REMARK 500 THR A 311 -147.19 -148.28 REMARK 500 ALA A 312 -66.96 -18.30 REMARK 500 ASP A 352 45.47 -103.17 REMARK 500 GLN A 358 48.03 -80.99 REMARK 500 PHE A 420 -18.75 -159.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HYF A 435 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ILG RELATED DB: PDB REMARK 900 APO FORM OF HPXR-LBD REMARK 900 RELATED ID: 1ILH RELATED DB: PDB REMARK 900 HPXR-LBD BOUND TO SR12813 DBREF 1M13 A 130 434 UNP O75469 PXR_HUMAN 130 434 SEQADV 1M13 MET A 119 UNP O75469 EXPRESSION TAG SEQADV 1M13 LYS A 120 UNP O75469 EXPRESSION TAG SEQADV 1M13 LYS A 121 UNP O75469 EXPRESSION TAG SEQADV 1M13 GLY A 122 UNP O75469 EXPRESSION TAG SEQADV 1M13 HIS A 123 UNP O75469 EXPRESSION TAG SEQADV 1M13 HIS A 124 UNP O75469 EXPRESSION TAG SEQADV 1M13 HIS A 125 UNP O75469 EXPRESSION TAG SEQADV 1M13 HIS A 126 UNP O75469 EXPRESSION TAG SEQADV 1M13 HIS A 127 UNP O75469 EXPRESSION TAG SEQADV 1M13 HIS A 128 UNP O75469 EXPRESSION TAG SEQADV 1M13 GLY A 129 UNP O75469 EXPRESSION TAG SEQRES 1 A 316 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 A 316 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 A 316 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 A 316 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 A 316 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 A 316 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 A 316 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 A 316 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 A 316 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 A 316 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 A 316 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 A 316 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 A 316 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 A 316 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 A 316 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 A 316 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 A 316 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 A 316 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 A 316 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 A 316 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 A 316 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 A 316 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 A 316 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 A 316 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 A 316 ILE THR GLY SER HET HYF A 435 39 HETNAM HYF 4-HYDROXY-5-ISOBUTYRYL-6-METHYL-1,3,7-TRIS-(3-METHYL- HETNAM 2 HYF BUT-2-ENYL)-6-(4-METHYL-PENT-3-ENYL)- HETNAM 3 HYF BICYCLO[3.3.1]NON-3-ENE-2,9-DIONE HETSYN HYF HYPERFORIN FORMUL 2 HYF C35 H52 O4 FORMUL 3 HOH *265(H2 O) HELIX 1 1 THR A 144 PHE A 162 1 19 HELIX 2 2 LYS A 198 LYS A 204 1 7 HELIX 3 3 ASP A 205 LEU A 209 5 5 HELIX 4 4 GLY A 233 SER A 238 5 6 HELIX 5 5 LEU A 239 ILE A 261 1 23 HELIX 6 6 ILE A 261 ASP A 266 1 6 HELIX 7 7 PRO A 268 VAL A 291 1 24 HELIX 8 8 GLY A 313 LEU A 319 1 7 HELIX 9 9 GLU A 321 LEU A 333 1 13 HELIX 10 10 HIS A 336 PHE A 349 1 14 HELIX 11 11 GLN A 358 ARG A 381 1 24 HELIX 12 12 GLN A 383 ARG A 387 5 5 HELIX 13 13 PHE A 388 HIS A 418 1 31 HELIX 14 14 THR A 422 GLY A 430 1 9 SHEET 1 A 5 VAL A 222 TYR A 225 0 SHEET 2 A 5 VAL A 211 ARG A 216 -1 N LEU A 213 O TYR A 225 SHEET 3 A 5 LEU A 304 LEU A 308 -1 O CYS A 307 N SER A 212 SHEET 4 A 5 THR A 298 CYS A 301 -1 N CYS A 301 O LEU A 304 SHEET 5 A 5 PHE A 292 ASN A 293 -1 N ASN A 293 O THR A 298 SITE 1 AC1 15 LEU A 209 LEU A 240 MET A 243 SER A 247 SITE 2 AC1 15 PHE A 281 CYS A 284 GLN A 285 PHE A 288 SITE 3 AC1 15 TRP A 299 MET A 323 HIS A 407 ILE A 414 SITE 4 AC1 15 PHE A 420 HOH A 471 HOH A 504 CRYST1 91.372 91.372 85.645 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010944 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010944 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011676 0.00000